Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Posts by this author

MOBILion Systems and Protein Metrics join forces to integrate the Byos® Software Suite

   30
MOBILion Systems and Protein Metrics join forces to integrate the Byos® Software Suite

Protein Metrics (Cupertino, CA) and MOBILion Systems Inc. (Chadds Ford, PA) announce their strategic partnership to provide data analysis modules for Protein Metrics’ Byos software suite that work exclusively with MOBILion’s High-Resolution Ion Mobility (HRIM) Mass Spectrometry (MS) System. Combining best in class data analysis with the fastest, highest resolution analysis of multiple Critical Quality Attributes (CQA) to accelerate biotherapeutic drug development and enhance characterization capabilities that affect product quality, safety, and efficacy.

SEPHA INTRODUCES NEWLY PATENTED 3D LEAK DETECTION TECHNOLOGY FOR BLISTER PACKS

   190
SEPHA INTRODUCES NEWLY PATENTED 3D LEAK DETECTION TECHNOLOGY FOR BLISTER PACKS

Belfast, UK, November 30, 2020: Sepha, a specialist in leak test solutions for the pharmaceutical packaging industry, will be introducing its newly patented 3D Leak Detection technology for pharmaceutical blister packs via two live online webinars on the 2nd and 3rd December 2020. Aimed at pharmaceutical manufacturers, the new technology incorporates a 3D sensor to provide volumetric measurement to assess the integrity of a range of pharmaceutical solid dose and flexible barrier packaging.

MOBILion and International Research Team are Awarded Grant from The Michael J. Fox Foundation

   178
MOBILion and International Research Team are Awarded Grant from The Michael J. Fox Foundation

MOBILion Systems, Inc., a pioneer in fast, efficient, high-resolution instrumentation for biomarker discovery, diagnostics and therapeutic development, is collaborating with an international research team to identify alterations in the metabolism of selective glycosphingolipids in specific brain regions that contribute to the early onset and progression of Parkinson’s disease.